I am guessing you meant to say in your opinion there is a flaw because the FDA Pre Licensing Inspection of Mesoblast's Lonza manufacturing facility didn't find any flaws in the Remestemcel-L product ? Who to believe - a disgruntled shareholder of a company years behind Mesoblast with pennies in the bank and CR incoming or the FDA regulator in the USA ? Hmmm ... enough said
banter and General Discussion, page-10323
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.040(3.62%) |
Mkt cap ! $1.295B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.15 | $1.08 | $3.272M | 2.947M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 88684 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 358718 | 21 |
View Market Depth
| Last trade - 15.15pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |